Table.
Drug-use evaluation results
| Criteria | Number of nursing home residents | |
|---|---|---|
| FDA-approved indications: | ||
| • | Anemia of chronic kidney disease (CKD) | 6 |
| • | Anemia associated with zidovudine-treated HIV patients | 0 |
| • | Anemia associated with cancer patients with non-myeloid malignancies and concomitant chemotherapy-induced anemia | 0 |
| • | Reduction of allogenic blood transfusion in surgery patients undergoing elective, non-cardiac, non-vascular surgery | 0 |
| Off-label indications: | ||
| • | Unspecified anemia | 11 |
| • | Anemia of chronic disease | 4 |
| • | Erythropoietin-resistant anemia | 1 |
| On any iron supplementation | 14 | |
| Dosing appropriate to weight | 17 | |
| Hemoglobin > 12 g/dL | 6 | |
| Hypertension (Systolic > 140, Diastolic > 90) | 5 | |
| Blood Pressure not measured | 4 | |